High materiality8/10
Tonix Pharmaceuticals price target raised to $27 from $25 at Raymond James
Why it may matterVerify against the original reporting
Upside potential supported by target increase.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Raymond James raises TNXP price target to $27 from $25; current price is $12.54.
- Raymond James raises TNXP PT to $27 from $25; current price $12.54.
Key facts
- 01
Target: $27
- 02
Posted price: $12.54
- 03
Analyst firm: Raymond James
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.